Table A12:
Probabilistic Reference Case Analysis Results—Cost-Effectiveness of MRgFUS Neurosurgery, Radiofrequency Thalamotomy, and Deep Brain Stimulation
| MRgFUS, Mean (95% CI) | RF, Mean (95% CI) | DBS, Mean (95% CI) | |
|---|---|---|---|
| Cost of primary surgery | $19,786 | $11,774 | $37,366 |
| Cost of monitoring | $814 | $814 | $3,307 |
| Cost of medications | $1,096 | $1,096 | $1,081 |
| Cost of reoperation | $1,731 | $1,030 | – |
| Cost of managing adverse events | $71 | $259 | $6,306 |
| Cost of battery replacement | – | – | $9,463 |
| Total cost | $23,497 (−22,044–$25,287) | $14,972 (−14,096–$16,051) | $57,523 (−55,507–$59,772) |
| Life-years | 4.63 | 4.63 | 4.63 |
| QALYs | 3.70 (3.48–3.89) | 3.63 (3.42–3.82) | 3.96 (3.75–4.14) |
Abbreviations: AE, adverse events; DBS, deep brain stimulation; MRgFUS, magnetic resonance guided focused ultra sound; RF, radiofrequency.